...
首页> 外文期刊>Medicinal chemistry >3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.
【24h】

3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.

机译:3D-QSAR CoMFA和CoMSIA研究苯并二吡唑类药物作为细胞周期蛋白依赖性激酶2抑制剂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cyclin dependent kinase 2 (CDK2) has appeared as an important drug target over the years with a multitude of therapeutic potentials. With the intention of designing compounds with enhanced inhibitory potencies against CDK2, the 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles series is presented here. The developed models showed a strong correlative and predictive capability having a cross validated correlation co-efficient of (r(2)(cv)) 0.699 for CoMFA and 0.794 for CoMSIA models. A very good conventional and predicted correlation co-efficients were also obtained: CoMFA (r(2)(ncv), r(2)(pred): 0.883, 0.754), CoMSIA (0.937, 0.815). The models were found to be statistically robust and are expected to be of an aid to design and/or prioritize drug likes for synthesis.
机译:多年来,细胞周期蛋白依赖性激酶2(CDK2)成为重要的药物靶标,具有多种治疗潜力。为了设计对CDK2具有增强抑制作用的化合物,此处介绍了对苯并二吡唑系列的3D-QSAR CoMFA和CoMSIA研究。所开发的模型显示出强大的相关性和预测能力,对于CoMFA模型,交叉验证的相关系数为(r(2)(cv))为0.699,对于CoMSIA模型为0.794。还获得了非常好的常规和预测相关系数:CoMFA(r(2)(ncv),r(2)(pred):0.883,0.754),CoMSIA(0.937,0.815)。发现该模型具有统计学上的稳健性,并有望帮助设计和/或确定合成药物的优先次序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号